Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer Prevention in Women with Sickle Cell Disease: A Scoping Review of HPV Vaccination and Cancer Screening.

Journal of women's health (2002)Ā·2026
Same author

BPI26-010: Rurality and Social Context Are Associated With Overtreatment of Clinical T1a Renal Masses in the United States.

Journal of the National Comprehensive Cancer Network : JNCCNĀ·2026
Same author

Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.

British journal of haematologyĀ·2026
Same author

BPI26-020: Rural Disparities in Definitive Therapy for Prostate Cancer in the United States, 2010-2022: A Population-Based SEER Analysis.

Journal of the National Comprehensive Cancer Network : JNCCNĀ·2026
Same author

Rural-urban variation in guideline-concordant management of early-stage kidney, prostate, and testicular cancer in the United States (2010-2022).

Urologic oncologyĀ·2026
Same author

BPI26-020: Rural Disparities in Definitive Therapy for Prostate Cancer in the United States, 2010-2022: A Population-Based SEER Analysis.

Journal of the National Comprehensive Cancer Network : JNCCNĀ·2026

Related Experiment Video

Updated: Jul 24, 2025

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.1K

Hairy Cell Leukemia: Hepatic Affinity Status Post Splenectomy.

Gurneel K Dhanesar1, Jonathan Livingston1, Michael Maroules2

  • 1Internal Medicine, New York Medical College at St. Mary's General Hospital, Passaic and St. Clare's Health, Denville, USA.

Cureus
|July 3, 2023
PubMed
Summary

Hairy cell leukemia (HCL) can relapse in the liver's portal system, even after splenectomy. This rare hepatic involvement highlights the need for further research into HCL's behavior.

Keywords:
bcellcytopeniahairy cell leukemiahematology-oncologyhepatologylymphomaoncologyrituximabsplenectomyvemurafenib

More Related Videos

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

4.5K
A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
08:04

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

Published on: June 11, 2019

15.9K

Related Experiment Videos

Last Updated: Jul 24, 2025

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
11:24

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

14.1K
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

4.5K
A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
08:04

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity

Published on: June 11, 2019

15.9K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Hairy cell leukemia (HCL) is a rare B-cell neoplasm.
  • Splenectomy is a treatment for HCL-related cytopenia.
  • Hepatic involvement in HCL is uncommon and poorly understood.

Observation:

  • A case study of an 88-year-old male with a history of splenectomy.
  • The patient presented with a relapse of classic hairy cell leukemia.
  • The leukemia infiltrated the hepatic portal system.

Findings:

  • This case demonstrates rare hepatic portal system involvement of hairy cell leukemia.
  • Sinusoidal endothelial cell infiltration was observed in the liver.
  • Relapse occurred despite previous splenectomy.

Implications:

  • Highlights the potential for HCL to involve the liver, even after spleen removal.
  • Suggests the hepatic portal system as a site for HCL relapse.
  • Underscores the need for better understanding and diagnostic approaches for rare HCL manifestations.